Imagabalin

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Imagabalin
Imagabalin.svg
Clinical data
ATC code None
Identifiers
Synonyms PD-0332334; PD-332,334
CAS Number 610300-07-7
610300-00-0 (hydrochloride)
PubChem (CID) 10236037
ChemSpider 8411525
Chemical and physical data
Formula C9H19NO2
Molar mass 173.253 g/mol
3D model (Jmol) Interactive image

Imagabalin (INN, USAN; PD-332,334) is a drug which acts as a ligand for the α2δ subunit of the voltage-dependent calcium channel,[1] with some selectivity for the α2δ1 subunit over α2δ2.[2] Under development by Pfizer as a pharmaceutical medication, it has demonstrated preclinical efficacy of anxiolytic, analgesic, hypnotic, and anticonvulsant-like activity and is currently in phase III clinical trials for the treatment of generalized anxiety disorder.[2][3]

See also[edit]

References[edit]